Skip to content

K-Beauty

Stem Cell Research and Healthy Longevity at the INNOCOS K-Beauty & Longevity Business Tour

Prof. Young Tak Kim explored stem cell research, healthspan and regenerative medicine at the INNOCOS K-Beauty & Longevity Business Tour in Seoul.

CHAUM presentation at INNOCOS

What should count as progress in longevity? At Chaum in Seoul, Prof. Young Tak Kim framed the question around healthspan, the years people spend in good health. His presentation at the 2026 INNOCOS K-Beauty & Longevity Business Tour explored how researchers study the body’s capacity for repair as we age, and what beauty and wellness leaders should ask as that science enters business conversations.

Prof. Kim, a gynecologic oncologist at the Gynecologic Cancer Centre at CHA Bundang Medical Centre, introduced the group to stem cell biology and emerging areas of regenerative medicine. The session brought a clinical perspective to a tour connecting international executives and founders with Korea’s aesthetics, longevity, manufacturing, and retail ecosystem.

What stem cell research can tell us about healthy ageing

Prof. Kim began by distinguishing between lifespan and healthspan. As people live longer, maintaining function and quality of life becomes an increasingly important goal. He used tissue repair to make that idea concrete, explaining how its capacity varies across the body and how researchers study changes in stem cell function as part of ageing biology.

He also introduced exosomes, tiny particles released by cells that can carry molecules involved in communication between cells. The discussion moved from the biology to a question about quality control. Attendees asked how researchers assess cells during preparation and what those checks can tell them. For business leaders, that exchange raised a second question. What evidence shows that a specific intervention produces a meaningful benefit in people?

Quality control helps characterise what is being studied. Clinical evidence addresses whether it is safe and effective for a specific use. Anti-ageing benefits from stem cell or exosome interventions remain unproven, and the U.S. FDA has warned about unapproved regenerative medicine products marketed with broad health claims.

Three questions for beauty and wellness leaders

  1. What outcome matters to the customer? Start with a specific benefit, such as improved skin hydration, and define how you’ll assess it. A measurable outcome gives product and marketing teams something concrete to work toward when developing a product around healthy ageing.
  2. Does the evidence match the offering? When reviewing a biotech partnership or an aesthetics innovation, ask what was studied, in whom, against what comparison and for how long. For a skincare launch, ask whether the evidence supports the claim on the finished formulation.
  3. How will you explain the science in each market? Review the language proposed for packaging, clinic materials and campaign briefs before launch. Give teams a plain-language explanation of what the evidence supports and where research is still underway.

Explore beauty, wellness and longevity with INNOCOS

The Chaum session showed what an industry visit can make possible. Executives could ask a practising clinician how an emerging technology is evaluated and bring those questions back to their own product, partnership and investment decisions.

INNOCOS brings together leaders across beauty, wellness, longevity, aesthetics and consumer health through international events and business tours. The 2026 Seoul program gave participants a firsthand look at Korean beauty innovation across clinics, manufacturers and retailers. Explore the INNOCOS Seoul program

Interested in a future INNOCOS summit or business tour? Request an invitation.